Abstract | OBJECTIVE: METHODS: HIV-infected individuals without clinical suspicion of active TB or a past history of TB were enrolled from 1 January 2008 to 30 November 2010. Both T-SPOT.TB test and TST were offered to the participants whom were followed up prospectively until April 30, 2012 for development of TB. RESULTS: Among the 909 participants, 25% had positive TST reactions with cut-off point of 5 mm and 15% had positive T-SPOT.TB results. After a median follow-up of 2.97 years, there were 5 cases developed culture-confirmed active TB (all had dual positive TST and T-SPOT.TB results), and the incidence was 0.17 per 100 person-years. The relative risks (RRs) for subsequent active TB in HIV-infected individuals with positive TST results, positive T-SPOT.TB results and dual positive results compared with the risk for individuals with negative results were 40.6 (95% CI 2.1-767.9), 73.9 (95% CI 3.9-1397.7) and 226.5 (95% CI 12.0-4284), respectively. The number needed to treat to prevent one subsequent TB case among patients with a positive TST, a positive T-SPOT.TB and dual positive results was 35, 22 and 8 respectively. CONCLUSIONS: Adopting positive results of the TST and T-SPOT.TB to screen LTBI among BCG-vaccinated HIV-infected individuals might be feasible. Number needed to treat for isoniazid preventive therapy could be reduced significantly by using dual positive strategy.
|
Authors | Chin-Hui Yang, Pei-Chun Chan, Say-Tsung Liao, Shu-Hsing Cheng, Wing-Wai Wong, Li-Min Huang, Po-Ren Hsueh, Hung-Yi Chiou |
Journal | PloS one
(PLoS One)
Vol. 8
Issue 8
Pg. e73069
( 2013)
ISSN: 1932-6203 [Electronic] United States |
PMID | 24015285
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antitubercular Agents
- Isoniazid
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antitubercular Agents
(administration & dosage)
- Female
- Follow-Up Studies
- HIV Infections
- Humans
- Isoniazid
(administration & dosage)
- Latent Tuberculosis
(diagnosis, drug therapy)
- Male
- Middle Aged
- Mycobacterium bovis
- Tuberculin Test
|